Zelia M. Correa, MD, PhD

Ophthalmologist, Division of Pediatric Ophthalmology

Ocular Oncology

Associate Professor, UC Department of Ophthalmology


Ocular oncology; retinoblastoma and childhood ocular benign and malignant tumors


Ocular oncology; ophthalmic pathology

Dr. Correa has been recognized by her academic achievements and her volunteer service/leadership in the profession of ophthalmology. She has received an achievement award (2010) and the international ophthalmologist education award (2009) from the American Academy of Ophthalmology. Additionally, she has been recognized by two Secretariat Awards also from the American Academy of Ophthalmology and has been the youngest Guest of Honor at their National Meeting in 2009. Here in Cincinnati, she has received the Dean’s Award for Excellence in Education (University of Cincinnati College of Medicine) in 2011.

Undergraduate: Faculdade Riopretense de Filosofia Ciências e Letras, São José do Rio Preto, Brazil.

MD: Faculdade Medicina de Rio Preto, São José do Rio Preto, Brazil, 1989.

Residency: Ophthalmology, Faculdade de Medicina de Marília, Brazil, 1992.       

Certification: Ophthalmology, 1992.

Fellowship: Vitreoretinal surgery, Brazil, 1995.

Fellowship: Ocular oncology, Wills Eye Hospital, Philadelphia, PA, 1996.  

PhD: UNIFESP (Federal university of São Paulo, SP, Brazil), 2003.

Post-doctoral fellowships: Ophthalmic pathology, Wills Eye Institute, Philadelphia, PA, 2005.

Ophthalmic pathology and translational research, McGill University-Montreal, QC, Canada, 2006.

View PubMed Publications

Correa ZM, Augsburger JJ. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications. Graefes Arch Clin Exp Ophthalmol. 2013 Nov 24. [Epub ahead of print].

Augsburger JJ, Corrêa ZM, Trichopoulos N. Prognostic implications of cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy. Arq Bras Oftalmol. 2013 Mar-Apr;76(2):72-9.

Onken MD, Worley LA, Char DH, Augsburger JJ, Correa ZM, Nudleman E, Aaberg TM Jr, Altaweel MM, Bardenstein DS, Finger PT, Gallie BL, Harocopos GJ, Hovland PG, McGowan HD, Milman T, Mruthyunjaya P, Simpson ER, Smith ME, Wilson DJ, Wirostko WJ, Harbour JW. Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma. Ophthalmology. 2012 Aug;119(8):1596-603.

Simoes CC, Call MK, Correa ZM, Spaulding AG, Augsburger JJ. Clinical and histopathological features and immunoreactivity of human choroidal and ciliary body melanomas as prognostic factors for metastasis and death. Graefes Arch Clin Exp Ophthalmol. 2011;249(12):1795-803.

Augsburger JJ, Correa ZM, Trichopoulos N. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Am J Ophthalmol. 2011 July;152(1):5-9.

Palakurthi NK, Correa ZM, Augsburger JJ, Banerjee RK. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study. J Ocul Pharmacol Ther. 2011 Apr;27(2):151-6.

Correa ZM, Marshall JC, Souza Filho JP, Odashiro AN, Burnier Jr MN. Fine needle aspiration biopsy to reestablish cell culture in an animal model of uveal melanoma. Arq Bras Oftalmol. 2009 Jul-Aug;72(4):515-8.

Augsburger JJ, Corrêa ZM, Shaikh AH. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Trans Am Ophthalmol Soc. 2008;106:128-35; discussion 135-7.

Augsburger JJ, Corrêa ZM, Trichopoulos N, Shaikh A. Size overlap between benign melanocytic choroidal nevi and choroidal malignant melanomas. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2823-8.

Augsburger JJ, Corrêa ZM, Schneider S, Yassin RS, Robinson-Smith T, Ehya H, Trichopoulos N. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category. Trans Am Ophthalmol Soc. 2002;100:225-32; discussion 232-4.